- Peritoneal surface malignancy spread - reoperations after cytoreductive surgery + HIPEC2021 | First Faculty of Medicine
- Personnel safety during cytoreductive surgery and hypertermic intraperitoneal chemotherapyPublication without faculty affiliation
- Peritoneal carcinomatosis of colorectal origin treated by cytoreductive surgery and hyperthermic intraoperative peritoneal chemotherapy at the Bulovka University Hospital2021 | First Faculty of Medicine
- Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation2013 | First Faculty of Medicine
- Current Clinical Practice in Cytoreductive Surgery for Advanced Ovarian Cancer A European Survey2011 | First Faculty of Medicine
- Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal metastases from colorectal cancer in the Czech Republic in 20182021 | First Faculty of Medicine
- Treatment of Malignant Peritoneal Mesothelioma2019 | First Faculty of Medicine
- Surgical treatment of advanced colorectal cancer2017 | First Faculty of Medicine
- Peritoneal Carcinomatosis of Gastric Origin - Treatment Possibilities2019 | First Faculty of Medicine
- Pulmonary metastases in pseudomyxoma peritonei - case report and review of the literature2020 | First Faculty of Medicine
- Malignant Peritoneal Tumors - Introduction2019 | First Faculty of Medicine
- Pseudomyxoma Peritonei2019 | First Faculty of Medicine
- HIPEC and other locoregional methods in clinical practicePublication without faculty affiliation
- Pseudomyxoma peritonei (PMP) and its therapy - 20 years' experience of a single surgical department2020 | First Faculty of Medicine
- Oncological outcome of surgical management in patients with recurrent uterine cancer-a multicenter retrospective cohort study-CEEGOG EX01 Trial2019 | First Faculty of Medicine
- Cancer Antigen 125: Lost to Follow-Up? A European Society of Gynaecological Oncology Consensus Statement2012 | First Faculty of Medicine
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours2021 | First Faculty of Medicine
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors2021 | First Faculty of Medicine
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors2021 | First Faculty of Medicine
- DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC2023 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Multiple organ resection for large paraganglioma - a case report2021 | Second Faculty of Medicine
- Uterus sparing surgery in adenomyosis and its impact on reproductive outcomes2022 | First Faculty of Medicine
- Enhanced myometrial vascularity2022 | First Faculty of Medicine
- Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance2013 | Third Faculty of Medicine
- The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review2017 | Faculty of Medicine in Hradec Králové
- Circulating tumor cells in gynaecological malignancies2020 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Circulating tumor cells in gynaecological malignanciesPublication without faculty affiliation
- New trends in systemic treatment of ovarian cancer2018 | Faculty of Medicine in Pilsen
- Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey2020 | First Faculty of Medicine
- Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer2021 | Faculty of Medicine in Hradec Králové